lobomycosis

Aquarium employees and farmers constitute most of the cases with lobomycosis.

Report of the first human case of lobomycosis in the United States.

There is no evidence of person-to-person transmission of lobomycosis [462].

Optional treatment of lobomycosis is surgical excision.

While there yet appears no optional medical therapy, clofazimine has been effective in some cases with lobomycosis [462, 1895].

Lacazia loboi gen. nov., comb, nov., the etiologic agent of lobomycosis.

In January 2006, a potential epidemic of lobomycosis was reported in dolphins of the Indian River Lagoon in Florida.

Treatment with antifungals has been considered ineffective, but the use of clofazimine and dapsone in patients with leprosy and lobomycosis has been found to improve the latter.

However, other pathogens can cause similar lesions and therefore paracoccidiodomycosis, histoplasmosis, sporotrichosis, lobomycosis, lupus vulgaris, Mycobacterium ulcerans, syphilis, cutaneous sarcoidosis, and leprosy should all be considered as well.

Lacazia loboi is the causative agent of a tropical mycosis, lobomycosis, which is characterized by mucocutaneous lesions, that are usually nodular, vegetating, verrucose, cauliflower-like and hyper- or hypopigmented.

While the name Loboa loboi is still frequently used to refer to the causative agent of lobomycosis, more recently, classification of the fungus in the genus Lacazia and conclusively, the name Lacazia loboi has been proposed by McGinnis et al. [2213].